Test Results For:
Glycosylated Hemoglobin (HbA1c)
Test Overview
Test Name
Glycosylated Hemoglobin (HbA1c)
Test Code
HBA1C
Short Description
HBA1C
Test Name
Glycosylated Hemoglobin (HbA1c)
Test Code
HBA1C
Category
Biochemistry
TAT
Main Lab:
6
Hour(s)
Family Site:
<8hrs
Specimen(s)
1 x Venous blood - 4000 mL Tube - Lavender - EDTA HbA1c
Specimen Type
EDTA HbA1c
Specimen Format
Tube
Specimen Colour
Lavender
Specimen Volume
4000 mL
Sampling Order
4
Origin
Venous blood
Collection Time after baseline
-
Transport Temperature
15-25°C
Accepted Other Specimens
EDTA Whole Blood
TAT
Main Lab:
6
Hour(s)
Family Site:
<8hrs
Test Stability
Room Temp:
3 Day(s)
2–8°C:
7 Day(s)
Methodology
Capillary electrophoresis
Specimen Type
EDTA HbA1c
Other Type of Specimen Accepted
EDTA Whole Blood
Delay before pre-treatment
-
Transport temperature
15-25°C
Test stability at room temperature
3 Day(s)
Test stability at 2–8°C
7 Day(s)
Haemolysis interference
No
Methodology
Capillary electrophoresis
Specimen Type
EDTA HbA1c
Other Type of Specimen Accepted
EDTA Whole Blood
Delay before pre-treatment
-
Transport temperature
15-25°C
Test stability at room temperature
3 Day(s)
Test stability at 2–8°C
7 Day(s)
Haemolysis interference
No
Methodology
Calculation
Specimen Type
EDTA HbA1c
Other Type of Specimen Accepted
EDTA Whole Blood
Delay before pre-treatment
-
Transport temperature
15-25°C
Test stability at room temperature
3 Day(s)
Test stability at 2–8°C
7 Day(s)
Haemolysis interference
No
Methodology
-
Specimen Type
EDTA HbA1c
Other Type of Specimen Accepted
EDTA Whole Blood
Delay before pre-treatment
-
Transport temperature
15-25°C
Test stability at room temperature
3 Day(s)
Test stability at 2–8°C
7 Day(s)
Haemolysis interference
No
Clinical Interest
HbA1c is used in the diagnosis of diabetes and prediabetes. It reflects average blood glucose levels over the past 2-3 months, providing a more stable and reliable measure compared to daily glucose monitoring. It's particularly useful for monitoring long-term glycemic control in diabetic patients.
For individuals with diabetes, HbA1c levels serve as a marker of average blood glucose levels over time. Regular monitoring helps healthcare providers assess the effectiveness of treatment plans and make adjustments as necessary to achieve target levels and prevent complications.
Elevated HbA1c levels are associated with an increased risk of diabetes-related complications such as cardiovascular disease, nephropathy, retinopathy, and neuropathy. Monitoring HbA1c levels helps identify patients at higher risk of developing these complications and allows for early intervention to prevent or delay their onset.
HbA1c levels guide treatment decisions in diabetes management. Lowering HbA1c levels through lifestyle changes, medication adjustments, and other interventions reduces the risk of long-term complications and improves overall health outcomes.
Clinical Information Required
Insulin Therapy
Patient Collection Note
-
LOINC Code
48-4, 4548-4
Outwork
No